Les Echos.fr - February 18, 2011
France's Sanofi-Aventis is developing vaccines, especially for emerging countries. When is an investigational vaccine for dengue fever in Thailand, Australia and South America for which Sanofi has invested a large slice of the 450 million is earmarked for R & D France has invested 300 million euro in the factory under construction in Neuville-sur-Saone. The company, in 2014, provides for an annual production of 100 million doses and vaccinations for about 3.5 billion.
0 comments:
Post a Comment